Johnson & Johnson
JNJ Healthcare Drug Manufacturers General
Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024. In the quarter to September 2026, revenue grew 5.86%, EPS was flat, free cash flow grew 154.8% and total debt fell 4.82%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.
Follow JNJ
Johnson & Johnson (JNJ) Total debt
Johnson & Johnson's total debt at the end of fiscal 2025 was $39.4B, up 28.7% from $30.7B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $37.3B. Over the past ten years it has ranged from $12.9B (fiscal 2015) to $39.4B (fiscal 2025) — the current reading is the highest in ten years. Johnson & Johnson ranks 8th of 21 Drug Manufacturers General companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $39.4B | 28.67% |
| FY2024 | $30.7B | 18.43% |
| FY2023 | $25.9B | (3.74%) |
| FY2022 | $26.9B | (10.34%) |
| FY2021 | $30.0B | (8.12%) |
| FY2020 | $32.6B | 23.18% |
| FY2019 | $26.5B | (4.30%) |
| FY2018 | $27.7B | (9.75%) |
| FY2017 | $30.7B | 36.69% |
| FY2016 | $22.4B | 74.55% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $37.3B | (0.49%) |
| Mar 2026 | $37.5B | (4.85%) |
| Dec 2025 | $39.4B | 0.08% |
| Sep 2025 | $39.4B | 0.44% |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| ABBV AbbVie Inc. compare | $70.8B |
| PFE Pfizer Inc. compare | $63.2B |
| AMGN Amgen Inc. compare | $57.3B |
| LLY Eli Lilly and Company compare | $54.9B |
| MRK Merck & Co., Inc. compare | $51.1B |
| NVS Novartis AG compare | $47.1B |
| JNJ Johnson & Johnson | $37.3B |
| AZN AstraZeneca PLC compare | $29.5B |
| GILD Gilead Sciences, Inc. compare | $26.2B |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on JNJ
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement